Skip to main content

Table 1 Best response with R-Dox.

From: Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)

Response Category Complete Response Partial Response Stable Disease
Clinical 12 (100%) - -
Biochemical 10 (83%) 1 (8%) 1 (8%)
Radiographic 6 (50%) 6 (50%) -
Overall 3 (25%) 6 (50%) 3(25%)